If a patient has liver disease, what is true about acetaminophen use?

Prepare for emergency medicine exams with our comprehensive test. Explore multiple choice questions, receive hints and explanations. Sharpen your knowledge and ensure success!

Multiple Choice

If a patient has liver disease, what is true about acetaminophen use?

Explanation:
In liver disease, acetaminophen is contraindicated because impaired hepatic metabolism increases the risk of toxic injury. The liver normally processes acetaminophen through pathways that handle most of the drug safely, but a portion is converted to a reactive metabolite that is detoxified by glutathione. When the liver is diseased, detox pathways are weaker and glutathione stores may be depleted, so even standard amounts can overwhelm defenses and cause hepatocellular damage. That’s why this drug is avoided in significant liver injury or disease. It isn’t guaranteed safe just because liver enzymes are normal—their level doesn’t reflect the liver’s full capacity to detoxify harmful metabolites. The route of administration (even if given intravenously) does not eliminate the risk, and doubling the dose would increase toxicity risk, not safety.

In liver disease, acetaminophen is contraindicated because impaired hepatic metabolism increases the risk of toxic injury. The liver normally processes acetaminophen through pathways that handle most of the drug safely, but a portion is converted to a reactive metabolite that is detoxified by glutathione. When the liver is diseased, detox pathways are weaker and glutathione stores may be depleted, so even standard amounts can overwhelm defenses and cause hepatocellular damage. That’s why this drug is avoided in significant liver injury or disease.

It isn’t guaranteed safe just because liver enzymes are normal—their level doesn’t reflect the liver’s full capacity to detoxify harmful metabolites. The route of administration (even if given intravenously) does not eliminate the risk, and doubling the dose would increase toxicity risk, not safety.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy